These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17768303)

  • 1. Patients with hemodynamically tolerated ventricular tachycardia require implantable cardioverter defibrillators.
    Callans DJ
    Circulation; 2007 Sep; 116(10):1196-203. PubMed ID: 17768303
    [No Abstract]   [Full Text] [Related]  

  • 2. All patients with hemodynamically tolerated postinfarction ventricular tachycardia do not require an implantable cardioverter-defibrillator.
    Almendral J; Josephson ME
    Circulation; 2007 Sep; 116(10):1204-12. PubMed ID: 17768304
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversed circadian rhythms of heart rate variability and morning peak occurrence of sustained ventricular tachyarrhythmias in patients with implanted cardioverter defibrillator.
    Sezgin A; Demircan S; Yalcin F
    Med Sci Monit; 2003 Feb; 9(2):LE1; author reply LE2. PubMed ID: 12643268
    [No Abstract]   [Full Text] [Related]  

  • 4. Delayed detection of stable ventricular tachycardia in a dual-chamber implantable cardioverter defibrillator: what is the mechanism?
    Strohmer B; Schernthaner C; Pichler M
    J Cardiovasc Electrophysiol; 2004 Feb; 15(2):244-6. PubMed ID: 15028059
    [No Abstract]   [Full Text] [Related]  

  • 5. Atrial fibrillation in patients with implantable defibrillators.
    Sakhuja R; Shah AJ; Keebler M; Thakur RK
    Cardiol Clin; 2009 Feb; 27(1):151-61, ix-x. PubMed ID: 19111771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators:
    Sweeney MO
    Pacing Clin Electrophysiol; 2004 Sep; 27(9):1292-305. PubMed ID: 15461721
    [No Abstract]   [Full Text] [Related]  

  • 7. Idiopathic polymorphic ventricular tachycardia with normal QT interval requiring implantable cardioverter-defibrillator device.
    Gambhir DS; Salwan R; Sharma VP; Kaul UA; Arora R
    Indian Heart J; 1996; 48(3):292-4. PubMed ID: 8755022
    [No Abstract]   [Full Text] [Related]  

  • 8. An electrical storm with more than 3000 shocks in a patient with an implantable cardioverter-defibrillator: is jet-lag a trigger?
    Han SW; Kim YN; Lee YS; Hyun DW; Kim D; Hur SH; Kim KS; Kim KB
    Int J Cardiol; 2005 Sep; 104(2):235-7. PubMed ID: 16168822
    [No Abstract]   [Full Text] [Related]  

  • 9. [Non-medicamentous therapy of tachycardic cardiac arrhythmias].
    Vester EG; Kuhls S; Perings C; Winter J; Bircks W; Strauer BE
    Internist (Berl); 1993 May; 34(5):452-65. PubMed ID: 8509255
    [No Abstract]   [Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator detection of repolarization alternans: uncovering a marker of electrical instability.
    Christini DJ; Lerman BB
    Heart Rhythm; 2006 Jul; 3(7):798-9. PubMed ID: 16818209
    [No Abstract]   [Full Text] [Related]  

  • 11. A single implantable cardioverter-defibrillator shock unmasking an electrical storm of 389 ventricular tachycardia episodes triggering device therapies.
    Arias MA; Valverde I; Puchol A; Castellanos E; Rodríguez-Padial L; Sánchez AM; Alvarez-Temiño M; Palomino M
    Am J Emerg Med; 2008 Nov; 26(9):1066.e1-3. PubMed ID: 19091283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to avoid inappropriate therapy.
    Israel CW
    Curr Opin Cardiol; 2008 Jan; 23(1):65-71. PubMed ID: 18281830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irregular ventricular tachycardia underdetected by implantable cardioverter defibrillator device.
    Manolis AG; Kourouklis S; Chatzis D; Kouvelas K; Kyriakides Z
    Cardiol J; 2008; 15(3):281-3. PubMed ID: 18651422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed detection of ventricular tachycardia in a dual chamber rate adaptive pacing implantable cardioverter defibrillator: a case of intradevice interaction.
    Strohmer B
    Pacing Clin Electrophysiol; 2005 Jan; 28(1):76-7. PubMed ID: 15660811
    [No Abstract]   [Full Text] [Related]  

  • 15. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-tachycardia pacing for ventricular tachycardia: good even after being bad.
    Arias MA; Puchol A; Castellanos E; Rodríguez-Padial L
    Europace; 2007 Nov; 9(11):1062-3. PubMed ID: 17666444
    [No Abstract]   [Full Text] [Related]  

  • 17. Caring for patients with third-generation implantable cardioverter defibrillators: from decision to implant to patient's return home.
    Knight L; Livingston NA; Gawlinski A; DeLurgio DB
    Crit Care Nurse; 1997 Oct; 17(5):46-51, 54-8, 60-1 passim; quiz 64-5. PubMed ID: 9355344
    [No Abstract]   [Full Text] [Related]  

  • 18. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worsening heart failure and recurrent untreated ventricular tachycardia in a CRT-D treated patient: why?
    Jefic D; Zein AM; Johnson KM; Pires LA
    Pacing Clin Electrophysiol; 2007 Oct; 30(10):1276-8. PubMed ID: 17897132
    [No Abstract]   [Full Text] [Related]  

  • 20. Ventricular tachycardia in an ice-hockey player after a blunt chest trauma.
    Schaer B; Osswald S; Sticherling C; Tartini R; Pfisterer M
    Int J Cardiol; 2007 Jan; 114(3):378-9. PubMed ID: 16603266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.